Do I Need a Prescription for Mounjaro?

Is Mounjaro available without a prescription?

No. Mounjaro is a prescription-only type 2 diabetes and weight loss medication. It can only be supplied against a valid prescription.

Mounjaro (tirzepatide) is licensed in the UK both for weight management and for type 2 diabetes. For either condition, a prescriber must review your medical history and agree the treatment suits you before you can take it. That rules out buying it over the counter or from a beauty salon. Fake Mounjaro pens have been sold online. You can only get the real thing from a registered pharmacy, and only with a prescription.

You can get a prescription in two ways, through the NHS or via private prescription. NHS treatment is funded, and the criteria for who qualifies are widening in stages. A private service is open to anyone who is eligible, but you pay for the consultation and the medicine. Dosing and reviews follow the licence, so our Mounjaro prescription guide applies either way. 

How do I get a Mounjaro prescription on the NHS?

Mounjaro is available on the NHS for weight management, but each UK nation sets its own criteria.

Who qualifies?

In most of the UK, NHS eligibility for Mounjaro depends on your BMI and how many weight-related health conditions you have.

Nation	Who can get it now	Where it is prescribed	What happens next
England	BMI 35 or above (for some ethnic groups), plus four or more weight-related conditionsLength	Primary care, or specialist weight management services	BMI 40 or above with three conditions from around March 2027. Full rollout may take up to 12 years.
Scotland	BMI 38 or above, or 35 for some ethnic groups, plus one weight-related condition	Weight management services, and other NHS settings that can give lifestyle advice	Plans to lower the BMI limit to 35, then 30
Wales	Through specialist weight management services, with named exceptions such as people waiting for cancer treatment, time-sensitive surgery or fertility treatment	Specialist weight management services	Routine GP prescribing not permitted
Northern Ireland	BMI over 45, plus one weight-related condition	A new obesity service opening in autumn 2026	Later phases planned

The conditions that count as a weight related co-morbidity are high blood pressure, abnormal cholesterol levels, obstructive sleep apnoea, heart disease and type 2 diabetes. Lower BMI thresholds apply if you are from a South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background. Each qualifying figure drops by 2.5 in those cases.

NICE recommended tirzepatide for managing patients who are overweight and patients living with obesity in December 2024, from a body mass index of 35 with one weight-related condition. NHS England is funding that recommendation in phases, and reaching everyone who meets the NICE threshold could take up to 12 years. The criteria your GP can prescribe against today are much tighter as a result.

How do I apply?

Your first step is your GP practice, they can check your medical history against the current eligibility criteria.

Mounjaro can be prescribed in primary care or through a specialist weight management service, depending on how your area is organised. A specialist weight management service is a team that combines nutritional, psychological and medical support, shaped around your needs. 

A healthcare professional will weigh you, confirm your height and assess your medical history. Waiting times vary between areas and no national figure has been published.

If you do not meet the criteria for the group that is currently able to access Mounjaro on the NHS, your GP practice can explain whether you may qualify in a later phase.

NICE recommends Mounjaro for type 2 diabetes separately, and this rollout does not affect those rules. 

How do I get a private Mounjaro prescription?

A private prescription for Mounjaro is one option if you cannot get NHS treatment where you live.

Private eligibility follows the licence, not the NHS criteria: a BMI of 30 or above, or 27 and above with a weight-related condition. Our prescribers also apply NICE’s lower BMI thresholds for some ethnic backgrounds, 2.5 below the figures above.

At Simple Online Pharmacy, our Mounjaro prices start at £129 a month for the lowest strength on a subscription, and £169 without. Higher strengths cost more, and prices vary between providers.

Private services sit outside the NHS rollout, but the assessment and checks still take time. This allows private prescribers to make sure the medication is suitable for you.

How do online prescription services work?

An online service assesses you remotely, and prescribing Mounjaro depends on the clinical team agreeing it suits you.

Check the pharmacy is registered before you order. The General Pharmaceutical Council covers England, Scotland and Wales. Northern Ireland has the Pharmaceutical Society of Northern Ireland.

Can a private GP or clinic prescribe Mounjaro?

A private GP or weight management clinic may be able to issue a prescription at the appointment, if the clinician considers treatment appropriate.

Expect the same ground as an online assessment: measured height and weight, plus questions about your medical history and current medicines. The clinic either dispenses it or gives you a prescription to take to a pharmacy.

What happens after I get a prescription?

Where do I collect Mounjaro, and what does it cost?

On the NHS, you collect your pens from a pharmacy and pay the prescription charge. Privately, the service that prescribes usually dispenses and delivers them directly to you.

In England, the NHS prescription charge is £9.90 per item, and prescriptions are free in Scotland, Wales and Northern Ireland. It stays the same whatever your dose. Private prices rise with the strength of the pen, so the £129 starting price applies only to the lowest dose.

What happens when I start treatment?

Starting treatment means collecting your Mounjaro pens and getting comfortable with the injection.

You inject Mounjaro yourself at home, using the pen it comes in. The main areas you can inject are your thigh, stomach, or the back of your arm. If you are not able to reach these areas, you can ask someone to help you.. 

Each of your Mounjaro pens holds four weekly doses, taken on the same day each week. Attach a new needle, prime the pen, and change the site each week, following the instructions for use in the box. 

Before starting treatment, read the patient information leaflet that comes with your pens. It includes common side effects and the full storage rules. Keep your pens in the fridge until first use, then somewhere no warmer than 30°C for up to 30 days before disposing the pen. Always make sure to take any used pens down to your local pharmacy for safe disposal.

How does the dose increase?

The licensed schedule begins at 2.5mg once weekly for four weeks, then rises in 2.5mg steps.

Each step needs at least four weeks at the current strength: 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. The licensed maintenance doses are 5mg, 10mg, and 15mg. You settle on one of those, with our clinical team reviewing and approving each increase. Not everyone reaches 15mg, because of side effects, cost or finding they have sufficient appetite suppression at the lower doses, and so don’t feel the need to move up.

How is treatment reviewed?

Treatment is intended for the long term, and you will be reviewed at regular periods whether you get your Mounjaro via the NHS or privately.

NICE advises a review after six months on the highest dose you tolerate. If you have lost less than 5% of your starting weight, you and your prescriber decide together whether continuing makes sense.

Are there non-prescription alternatives to Mounjaro?

Lower-dose orlistat is the one weight loss medicine you can buy without a prescription in the UK.

The NHS confirms it is sold from pharmacies under the brand name Alli or Orlos. Orlistat reduces how much fat your body absorbs from food, so it works in the gut rather than on appetite. The prescription strength brand name is Xenical. Weight loss injections are prescription-only medicines in the UK.

Diet and activity still matter alongside any weight loss medicine. The NHS advises at least 150 minutes of moderate activity a week, or 75 minutes of vigorous activity, with strengthening exercises on two days. Some people find that support from a dietitian or a group makes those changes easier to keep up.

When should I see a doctor?

Most Mounjaro side effects affect the stomach and gut.

Nausea, diarrhoea, vomiting, constipation, stomach pain, tiredness and reduced appetite are all common. In the SURMOUNT-1 trial, they were mostly mild to moderate and concentrated while the dose was rising. Tell your prescriber if you have had pancreatitis or a severe digestive condition.

Contact our clinical team if you have:

• Nausea, vomiting, diarrhoea or constipation that persists but stays manageable
• Heartburn, reflux, or a change in appetite that concerns you
• Questions about moving up a dose, staying put, or pausing treatment

Contact your GP or call NHS 111 if you have:

• Yellowing of the skin or eyes, or severe pain in the upper right of your abdomen, a possible sign of gallbladder problems
• Vomiting or diarrhoea persistent enough that you cannot keep fluids down, because dehydration can affect your kidneys
• Symptoms of low blood sugar, if you also take insulin or a sulfonylurea for diabetes

Stop Mounjaro and call 999 or go to A&E if you notice any of the following:

• Severe abdominal pain that spreads through to your back, which can be a sign of pancreatitis
• Swelling of the face, lips or throat, or any difficulty breathing
• Signs of severe dehydration, such as passing very little urine or feeling faint
• Blurring of vision in either or both eyes.

The UK medicines regulator, the MHRA, reviewed GLP-1 treatments in 2024. It found no evidence that they cause suicidal thoughts or behaviour. If you ever have thoughts of self harm, go to A&E and ask for the CRISIS team. 

Frequently asked questions

Do you need a prescription for Mounjaro?

Yes. Mounjaro is classed as a prescription-only medicine across the UK. A service offering it without requiring a valid prescription should not be used.

Can I get Mounjaro on prescription from my GP?

Your GP can prescribe it if you meet the criteria that apply where you live. If you fall outside them, your practice can still confirm where you sit and what the timing looks like.

Is a Mounjaro prescription UK-wide, or limited to one nation?

A private prescription from a UK prescriber can be taken to a registered pharmacy anywhere in the UK, though online services normally dispense their own. NHS supply is arranged through the service that prescribed it.

Can I stay on Mounjaro long term?

Mounjaro is licensed as an ongoing treatment rather than a short course. In the SURMOUNT-4 trial, participants who switched to a placebo after 36 weeks regained about 14% of their body weight over the next year.

Key takeaways

• Mounjaro is a prescription-only medicine everywhere in the UK.
• Where you live changes what you can get. Scotland treats from a BMI of 38 with one weight-related condition, England from 40 with four. 
• Northern Ireland opens its first obesity service in early autumn 2026, from a BMI above 45 with one weight-related condition. 
• Private treatment follows the licence rather than NHS funding rules: a BMI of 30, or 27 alongside a weight-related condition.
• Private costs differ between providers and rise with the dose.

References

Tirzepatide for managing overweight and obesity (TA1026), National Institute for Health and Care Excellence, 2024 [Accessed 24 September 2026].

Interim commissioning guidance for NICE TA1026 tirzepatide, NHS England, 2025 [Accessed 24 September 2026].

Tirzepatide (Mounjaro) for weight management, SMC2653, Scottish Medicines Consortium, 2024 [Accessed 24 September 2026].

Consensus statement: national criteria for the prioritisation of GLP-1 RAs and GLP-1 RA/GIP RAs for the treatment of obesity in NHS Scotland, NHS Scotland, September 2024 [Accessed 24 September 2026].

New clinical pathway for treating and managing obesity (WHC/2025/043), Welsh Government, 2025 [Accessed 24 September 2026].

Health Minister announces first phase of NI’s first Obesity Management Service, Department of Health (Northern Ireland), 2026 [Accessed 24 September 2026].

NI to get its first Obesity Management Service, Department of Health (Northern Ireland), 2025 [Accessed 24 September 2026].

Search the Register, Pharmaceutical Society of Northern Ireland [Accessed 24 September 2026].

Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen, Summary of Product Characteristics, electronic medicines compendium [Accessed 24 September 2026].

Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen, Patient Information Leaflet, electronic medicines compendium [Accessed 24 September 2026].

Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen, User Manual, electronic medicines compendium [Accessed 24 September 2026].

Tirzepatide, NHS [Accessed 24 September 2026].

Supplying medicines for weight management, General Pharmaceutical Council, 2026 [Accessed 24 September 2026].

MHRA finds no link between GLP-1 receptor agonists and suicidal behaviour, The Pharmaceutical Journal, 2024 [Accessed 24 September 2026].

Tirzepatide Once Weekly for the Treatment of Obesity, New England Journal of Medicine, 2022 [Accessed 24 September 2026].

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial, JAMA, 2024 [Accessed 24 September 2026].

Tirzepatide for treating type 2 diabetes (TA924), National Institute for Health and Care Excellence, 2023 [Accessed 24 September 2026].

Orlistat, NHS [Accessed 24 September 2026].

Physical activity guidelines for adults aged 19 to 64, NHS [Accessed 24 September 2026].

NHS prescription charges in England, CBP-10671, House of Commons Library, 2026 [Accessed 24 September 2026].

Authorship